LeaderPortfolio
Hamied
M
Rank #3163
INDIAHealthcarePharmaceuticals

Mustafa Hamied

Net Worth
$1.138B
0% (24h)
Mustafa Hamied, a prominent figure in the pharmaceutical sector, is recognized for his pivotal role in expanding Cipla into a leading global company. With a net worth of $1.8 billion (2024), Hamied's wealth stems primarily from his leadership at Cipla, a major pharmaceutical company. His career, beginning with Cipla, has been marked by a commitment to accessible healthcare and affordable medicines, especially in developing countries. Educated with a Doctorate in Philosophy from the University of California, San Francisco, Hamied is known for his philanthropic efforts, primarily in healthcare and education. His work has had a significant impact on global health culture, driving innovation and expansion in the healthcare industry. He is considered a blend of entrepreneurial success and social responsibility.

The Full Dossier

Early Life and Education

While specific details of Mustafa Hamied's early life are not widely publicized, his background laid the foundation for his future in pharmaceuticals. He pursued higher education, culminating in a Doctorate in Philosophy from the University of California, San Francisco. His family's legacy within the pharmaceutical industry, particularly through Cipla, likely influenced his career path from an early age, preparing him to eventually take the helm of the company.

Rise to Success

Mustafa Hamied's career began within the pharmaceutical sector, building upon the foundation established by his family's company, Cipla, founded in 1935. His early contributions focused on research and development. A major breakthrough came with the expansion and strategic direction of Cipla. He is celebrated for his commitment to making essential medicines accessible and affordable in developing countries. His contributions to the industry have made him a prominent figure in the global pharmaceutical sector.

Key Business Strategies

Hamied's success is largely attributed to his leadership and expansion of Cipla. He has strategically invested in healthcare startups and biotechnology firms, showcasing a diversified approach within the health sector. This focus on generics and affordability has positioned Cipla as a key player in the global pharmaceutical market.

Philanthropy

Mustafa Hamied is deeply committed to philanthropy, with a strong focus on accessible healthcare and education. He supports organizations like the Hamied Foundation and has launched initiatives to provide affordable medicines in rural areas.

Career Timeline

2024

Resignation from Cipla Board

Resigned from his position as Vice Chairman and Non-Executive Director of Cipla due to age and health.

1990s

Expanded Cipla

Played a key role in expanding and strategically directing Cipla, making essential medicines accessible and affordable.

1961

Joined Cipla

Mustafa Hamied joined Cipla, the company his father founded, and began his career in the pharmaceutical industry.

1935

Foundation of Cipla

Cipla was founded by Mustafa's father, Khwaja Abdul Hamied. Mustafa later played a key role in its expansion.

Philanthropic Impact

Healthcare & EducationUndisclosed

Hamied Foundation

Supports various healthcare and educational initiatives.

HealthcareUndisclosed

Affordable Medicines in Rural Areas

Initiatives to provide affordable medicines in rural areas.

Public HealthUndisclosed

Yusuf Hamied Fellowship Program

Launched at Columbia University's Mailman School of Public Health, fostering interdisciplinary research to tackle pressing public health issues in India.

Wealth Trajectory